Biggest exporter of medicine in world code#
Tinier percentages came from suppliers of drugs and medicines in Latin America (0.7%) excluding Mexico but including the Caribbean, Oceania (0.31%) led by Australia and New Zealand, then Africa (0.26%).įor research purposes, the 4-digit Harmonized Tariff System code prefixes for drugs and medicines are: In second place were pharmaceutical exporters in Asia at 9.9% while another 8.9% of worldwide drugs and medicine shipments originated from providers in North America. Collectively, that quintet of major pharmaceutical suppliers generated about half (49.9%) of globally exported drugs and medicines in 2022.Īmong continents, European countries sold the highest dollar value worth of exported drugs and medicines during 2022 with shipments from Europe accumulating to $358.2 billion or 79.9% of the global total.
The top 5 exporters of drugs and medicines are Germany, Switzerland, Belgium, United States of America and Italy. There was also a 6.5% year-over-year upturn compared to $450.5 billion during 2021. Overall the value of exported drugs and medicines delivered via international markets expanded by an average 22.9% for all exporting countries since 2018 when drugs and medicines shipments were valued at $373 billion. The company’s Consumer Healthcare (CHC) business division develops and markets over-the-counter (OTC) products in India and employed 38,000 people.Prescription drug salesGlobal sales from worldwide exports of drugs and medicines totaled US$458.4 billion in 2022.
Sun Pharma classifies its business into three categories namely, Formulations, API, and Others. The company reported revenue of $4,533 million with average revenue growth of 2.1%. The company manufactures and supplies more than 400 generic (branded and non-branded) pharmaceuticals to treat conditions such as diabetes, central nervous system disorders, central vascular system disorders, and respiratory and infectious diseases, and markets these drugs in various dosage forms such as tablets/capsules, semi-solids, liquids, and suppositories. India-based Sun Pharmaceutical Industries Ltd is one of the top Global Generic Companies in 2021 by revenue (FY 2021). The company reported revenue of $16,659 million and employed 34,713 people. The company provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, dermatology, cancer, women’s health, and other disease conditions. It discovers, develops, manufactures, and commercializes generic and specialty medicines. Israel-based Teva Pharmaceutical Industries Ltd is one of the top Global Generic Companies in 2021 by revenue (FY 2021). They employed a total of 173,859 people in 2021.
In terms of the geographical split, 9 out of 10 Global Generic Companies are based in Asia, while 1 is based in North America. The highest revenue growth was registered by Towa Pharmaceutical Co Ltd (40.33%), followed by Cipla Ltd (11.84%), while Teva Pharmaceutical Industries Ltd reported a decline in its revenues by 4.69%. Cumulatively, the top 10 Global Generic Companies generated revenue of $37,454 million, with average revenue growth of 6.97%, the highest revenue was generated by Teva Pharmaceutical Industries Ltd ($16,659 million), followed by Sun Pharmaceutical Industries Ltd ($4,533 million) and Cipla Ltd ($2,593 million). Reddy's Laboratories Ltd, and Lupin Ltd are the top 5 Global Generic Companies in 2021 by revenue. Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr.
0 kommentar(er)
